Logo-aim
Arch Iran Med. 2023;26(2): 69-75.
doi: 10.34172/aim.2023.12
PMID: 37543926
PMCID: PMC10685895
Scopus ID: 85164782166
  Abstract View: 1569
  PDF Download: 629

COVID-19

Original Article

Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations

Farzane Zare Ashrafi 1 ORCID logo, Marzieh Mohseni 1,2 ORCID logo, Maryam Beheshtian 1,2, Zohreh Fattahi 1,2, Fatemeh Ghodratpour 1, Fatemeh Keshavarzi 1, Hanieh Behravan 1, Marzieh Kalhor 1, Khadijeh Jalalvand 1, Maryam Azad 2, Mahdieh Koshki 2, Ali Jafarpour 3,4, Azam Ghaziasadi 3, Alireza Abdollahi 5, Seyed Jalal Kiani 6, Angila Ataei-Pirkooh 6, Iman Rezaei Azhar 3, Farah Bokharaei-Salim 6, Mohammad Reza Haghshenas 7, Farhang Babamahmoodi 7, Zakiye Mokhames 8, Alireza Soleimani 9, Masood Ziaee 10, Davod Javanmard 10, Shokouh Ghafari 10, Akram Ezani 11, Alireza Ansari Moghaddam 12, Fariba Shahraki-Sanavi 12, Seyed Mohammad Hashemi Shahri 13, Azarakhsh Azaran 14, Farid Yousefi 15, Afagh Moattari 16, Mohsen Moghadami 17, Hamed Fakhim 18, Behrooz Ataei 18, Elahe Nasri 18, Vahdat Poortahmasebi 19, Mojtaba Varshochi 20, Ali Mojtahedi 21, Farid Jalilian 22, Mohammad Khazeni 23, Abdolvahab Moradi 24, Alijan Tabarraei 24, Ahmad Piroozmand 25, Yousef Yahyapour 26, Masoumeh Bayani 26, Amir Aboofazeli 3, Parsa Ghafari 3, Fariba Keramat 27, Mahsa Tavakoli 28, Tahmineh Jalali 28,29, Mohammad Hassan Pouriayevali 28,29, Mostafa Salehi-Vaziri 28,29, Hamid Reza Khorram Khorshid 1, Reza Najafipour 1,30, Reza Malekzadeh 31, Kimia Kahrizi 1, Seyed Mohammad Jazayeri 3, Hossein Najmabadi 1,2* ORCID logo

1 Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
2 Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran
3 Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
4 Gerash Amir-al-Momenin Medical and Educational Center, Gerash University of Medical Sciences, Gerash, Iran
5 Department of Pathology, School of Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Iran
6 Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
7 Department of Medical Microbiology, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
8 Department of Molecular Diagnostic, Emam Ali Educational and Therapeutic Center, Alborz University of Medical Sciences, Karaj, Iran
9 Department of Infectious Diseases, Imam Ali hospital, Alborz University of Medical Sciences, Karaj, Iran
10 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
11 Qazvin Deputy of Treatment Reference Laboratory, Qazvin University of Medical Sciences, Qazvin, Iran
12 Health Promotion Research Center, Zahedan University of Medical Science, Zahedan, Iran
13 Infection Disease and Tropical Medicine Research Center, Zahedan University of Medical Science, Zahedan, Iran
14 Department of Medical Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
15 Department of Infectious Diseases, School of Medicine, Razi Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
16 Department of Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
17 Health policy research center, Shiraz University of medical sciences, Shiraz, Iran
18 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
19 Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
20 Infectious and Tropical Disease Research Center, Tabriz University of Medical Science, Tabriz, Iran
21 Microbiology Department, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
22 Department of Medical Virology, Faculty of Medicine, Hamadan University of Medical sciences, Hamadan, Iran
23 Booali lab, Molecular & Virology Diagnostic Section, Qom, Iran
24 Golestan University of Medical Sciences, Gorgan, Iran
25 Department of Microbiology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
26 Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran
27 Brucellosis Research Center, Hamedan University of Medical Science, Hamadan, Iran
28 COVID-19 National Reference Laboratory, Pasteur Institute of Iran, Tehran, Iran
29 Department of Arboviruses and Viral Hemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Tehran, Iran
30 Cell and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
31 Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Hossein Najmabadi, Email: hnajm12@yahoo.com

Abstract

Background: Global real-time monitoring of SARS-CoV-2 variants is crucial to controlling the COVID-19 outbreak. The purpose of this study was to set up a Sanger-based platform for massive SARS-CoV-2 variant tracking in laboratories in low-resource settings.

Methods: We used nested RT-PCR assay, Sanger sequencing and lineage assignment for 930-bp of the SARS-CoV-2 spike gene, which harbors specific variants of concern (VOCs) mutations. We set up our platform by comparing its results with whole genome sequencing (WGS) data on 137 SARS-CoV-2 positive samples. Then, we applied it on 1028 samples from March-September 2021.

Results: In total, 125 out of 137 samples showed 91.24% concordance in mutation detection. In lineage assignment, 123 out of 137 samples demonstrated 89.78% concordance, 65 of which were assigned as VOCs and showed 100% concordance. Of 1028 samples screened by our in-house method, 78 distinct mutations were detected. The most common mutations were: S:D614G (21.91%), S:P681R (12.19%), S:L452R (12.15%), S:T478K (12.15%), S:N501Y (8.91%), S:A570D (8.89%), S:P681H (8.89%), S:T716I (8.74%), S:L699I (3.50%) and S:S477N (0.28%). Of 1028 samples, 980 were attributed as VOCs, which include the Delta (B.1.617.2) and Alpha (B.1.1.7) variants.

Conclusion: Our proposed in-house Sanger-based assay for SARS-CoV-2 lineage assignment is an accessible strategy in countries with poor infrastructure facilities. It can be applied in the rapid tracking of SARS-CoV-2 VOCs in the SARS-CoV-2 pandemic.


Cite this article as: Zare Ashrafi F, Mohseni M, Beheshtian M, Fattahi, Z, Ghodratpour F, Keshavarzi F, et al. Implementation of an in-house platform for rapid screening of SARS-CoV-2 genome variations. Arch Iran Med. 2023;26(2):70-75. doi: 10.34172/aim.2023.12
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1570

Your browser does not support the canvas element.


PDF Download: 629

Your browser does not support the canvas element.

Submitted: 12 Jul 2022
Revision: 18 Oct 2022
Accepted: 16 Nov 2022
ePublished: 01 Feb 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)